Photopic negative response
Showing 1 - 25 of >10,000
Optical Coherence Tomography Angiography and Photopic Negative
Completed
- Open Angle Glaucoma
- Optical Coherence Tomography- Angiography
- Photopic negative response
-
Banhā, Benha, EgyptBenha University
Oct 29, 2021
Triple Negative Breast Tumors Trial (Xiaopi granules, Xiaopi decoction, Placebo)
Not yet recruiting
- Triple Negative Breast Neoplasms
- Xiaopi granules
- +2 more
- (no location specified)
Nov 22, 2023
Checkpoint Inhibitors in Triple Negative Breast
Recruiting
- Triple Negative Breast Cancer
- Whole Genome Sequencing
- +7 more
-
Barcelona, SpainVall d'Hebron Institute of Oncology
Jun 20, 2023
Breast Cancer, Contrast Enhanced Ultrasound Trial in Hershey (Lumason)
Not yet recruiting
- Breast Cancer
- Contrast Enhanced Ultrasound
-
Hershey, PennsylvaniaPenn State Health College of Medicine
Jul 19, 2023
Multiple Myeloma Trial (Continued treatment adapted to the response)
Completed
- Multiple Myeloma
- Continued treatment adapted to the response
- (no location specified)
Jan 14, 2023
Edema, Erythema, Estrogen Receptor Negative Trial in Houston (Laboratory Biomarker Analysis, Pembrolizumab)
Active, not recruiting
- Edema
- +8 more
- Laboratory Biomarker Analysis
- Pembrolizumab
-
Houston, TexasM D Anderson Cancer Center
Jan 23, 2023
BRCA and NACT in TNBC Patients
Completed
- Triple-Negative Breast Cancer
- BRCA1/2 genetic testing
-
Rome, RM, ItalyFondazione Policlinico Universitario Agostino Gemelli IRCCS
Feb 20, 2023
Immune Environment in Response to Therapy in Breast Cancer
Recruiting
- Breast Cancer
- +3 more
- Collection of personal health information from women treated at the University of Pennsylvania under an approved HIPAA waiver.
-
Philadelphia, PennsylvaniaAbramson Cancer Center
Sep 15, 2022
Stress Response, Multitasking Behavior, Mental Stress Trial (100% Cranberry Juice, 100% Cranberry Juice + 200 mg L-theanine,
Not yet recruiting
- Stress Response
- +5 more
- 100% Cranberry Juice
- +2 more
- (no location specified)
Sep 27, 2023
Epigenetic Silencing of MicroRNA for Predicting Therapeutic
Active, not recruiting
- Head and Neck Squamous Cell Carcinoma
- Not interventional
-
Albuquerque, New MexicoUniversity of New Mexico - Cancer Center
Oct 4, 2022
Radiation OmisSion in PAtients With CLinically Node Negative
Not yet recruiting
- Breast Cancer
- (no location specified)
May 10, 2023
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Trial
Not yet recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +3 more
- Pembrolizumab
- +5 more
- (no location specified)
Apr 12, 2023
Triple-negative Breast Cancers in Order to Validate Interest of
Not yet recruiting
- Triple Negative Breast Cancer
- Organoid
- Establishment of ex vivo breast cancer organoid models
-
Caen, FranceCentre François Baclesse
Aug 9, 2022
Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Using
Recruiting
- HER2 Negative Breast Cancer
- Response monitoring (no intervention)
-
Albuquerque, New MexicoUniversity of New Mexico Comprehensive Cancer Center
Apr 21, 2022
Breast Cancer, Triple Negative Breast Cancer Trial in New York (Sodium (Na) Magnetic Resonance Imaging (MRI), Dynamic Contrast-
Terminated
- Breast Cancer
- Triple Negative Breast Cancer
- Sodium (Na) Magnetic Resonance Imaging (MRI)
- Dynamic Contrast- Enhanced (DCE) MRI
-
New York, New YorkNYU Langone Health
Aug 1, 2022
Anatomic Stage IIB Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8
Active, not recruiting
- Anatomic Stage IIB Breast Cancer AJCC v8
- +19 more
-
Gilbert, Arizona
- +4 more
Dec 6, 2022
Triple Negative Breast Cancer, Breast Cancer Trial in United States (Carboplatin, Docetaxel, Doxorubicin)
Recruiting
- Triple Negative Breast Cancer
- Breast Cancer
- Carboplatin
- +4 more
-
Fairway, Kansas
- +5 more
Jan 26, 2023
HER2-negative Breast Cancer, Neoadjuvant Therapy, Pathological Complete Response Trial in Beijing (Camrelizumab with vinorelbine
Recruiting
- HER2-negative Breast Cancer
- +5 more
- Camrelizumab with vinorelbine and cisplatin
-
Beijing, Beijing, ChinaPeking University First Hospital
Oct 15, 2022
Glaucoma Trial in Seongnam (Nicotinamide(Mitovita), Placebo)
Recruiting
- Glaucoma
- Nicotinamide(Mitovita)
- Placebo
-
Seongnam, Bundang-gu, Korea, Republic ofCHA University Bundang Medical Center
Oct 9, 2023
Locally Recurrent/Metastatic Triple Negative Breast Cancer Trial in United States (radiation, drug, procedure)
Recruiting
- Locally Recurrent/Metastatic Triple Negative Breast Cancer
- external beam radiation therapy
- +2 more
-
Basking Ridge, New Jersey
- +6 more
Aug 8, 2022
Triple Negative Breast Cancer, Metastatic Breast Cancer Trial in Boston (Pembrolizumab, PVX-410)
Active, not recruiting
- Triple Negative Breast Cancer
- Metastatic Breast Cancer
- Pembrolizumab
- PVX-410
-
Boston, Massachusetts
- +2 more
Dec 21, 2022
Triple Negative Breast Cancer, Chemo Effect, Simvastatin Adverse Reaction Trial in Jakarta Pusat (Simvastatin 40mg, Placebo)
Recruiting
- Triple Negative Breast Cancer
- +2 more
- Simvastatin 40mg
- Placebo
-
Jakarta Pusat, DKI Jakarta, IndonesiaDr. Cipto Mangunkusumo National Central General Hospital
Sep 22, 2022
Triple Negative Breast Cancer, Vitamin D Deficiency, Invasive Breast Cancer Trial in Winston-Salem (drug, dietary supplement,
Recruiting
- Triple Negative Breast Cancer
- +2 more
- Standard of Care Neoadjuvant Chemotherapy
- +2 more
-
Winston-Salem, North CarolinaWake Forest Baptist Health Sciences
Feb 8, 2022
TNBC - Triple-Negative Breast Cancer, Breast Cancer Trial (Pembrolizumab, Radiation Therapy, Axatilimab)
Not yet recruiting
- TNBC - Triple-Negative Breast Cancer
- Breast Cancer
- Pembrolizumab
- +2 more
- (no location specified)
Aug 4, 2022
Metastatic Breast Cancer Trial in Amsterdam (Nivolumab, Cisplatin, Low dose doxorubicin)
Recruiting
- Metastatic Breast Cancer
- Nivolumab
- +2 more
-
Amsterdam, NetherlandsAntoni van Leeuwenhoek
Mar 21, 2022